Purpose: To explore the retinal and choroidal thicknesses (RT, CT), as measured using enhanced depth imaging (EDI) optical coherence tomography (OCT, Spectralis) in highly myopic eyes and its relationship with visual function. Materials and Methods: Prospective, case-control, noninterventional clinical study. CT was measured by EDI-OCT in highly myopic eyes (≥6 dpt) without any macular diseases and age-matched control eyes. A complete ophthalmological examination, visual acuity assessment and MP1 microperimetry were obtained. Results: 38 myopic (15 M/23 F, mean age 51 ± 8.9 years) and 21 control eyes (5 M/16 F, mean age 50 ± 5.4 years) were included. The myopic mean refractive error was -13.3 ± 4.9 dpt and axial length 29.2 ± 2.2 mm. The mean best-corrected visual acuity (BCVA) was lower in highly myopic than in control eyes (77.3 ± 9.25 vs. 84.8 ± 0.6 letters, p = 0.0001, respectively) as was the mean retinal sensitivity (MRS; 16.32 ± 2.6 vs. 19.9 ± 0.2 dB, p < 0.0001). While RT was similar between groups (291.5 ± 24.2 vs. 283.6 ± 13.9 µm, p = 0.06, respectively), subfoveal CT was thinner in highly myopic compared to control eyes (114.3 ± 78.5 vs. 272.6 ± 110.2 µm, p < 0.0001). A significant relationship was found between subfoveal CT and MRS (R2 = 0.22; p = 0.003) and BCVA (R2 = 0.13; p = 0.027). Conclusions: Macular function is reduced in highly myopic eyes without any visible macular diseases compared to controls, and a significant proportion of the macular function variability seems to be related to a reduced CT.

Keywords:
Choroid, Choroidal thickness, Retinal sensitivity, Microperimetry, Myopia, Optical coherence tomography
1.
Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT: Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-658.
2.
Bar Dayan Y, Levin A, Morad Y, Grotto I, Ben-David R, Goldberg A, et al: The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys. Invest Ophthalmol Vis Sci 2005;46:2760-2765.
3.
Lin LL, Shih YF, Hsiao CK, Chen CJ: Prevalence of myopia in Taiwanese schoolchildren: 1983-2000. Ann Acad Med Singapore 2004;33:27-33.
4.
Chui TY, Yap MK, Chan HH, Thibos LN: Retinal stretching limits peripheral visual acuity in myopia. Vision Res 2005;45:593-605.
5.
Lai TY, Fan DS, Lai WW, Lam DS: Peripheral and posterior pole retinal lesions in association with high myopia: a cross-sectional community-based study in Hong Kong. Eye (Lond) 2008;22:209-213.
6.
Buch H, Vinding T, La Cour M, Appleyard M, Jensen GB, Nielsen NV: Prevalence and causes of visual impairment and blindness among 9,980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology 2004;111:53-61.
7.
Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y: Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 2006;113:1354-1362.
8.
Hirata A, Negi A: Morphological changes of choriocapillaris in experimentally induced chick myopia. Graefes Arch Clin Exp Ophthalmol 1998;236:132-137.
9.
Grossniklaus HE, Green WR: Pathologic findings in pathologic myopia. Retina 1992;12:127-133.
10.
Kitaguchi Y, Bessho K, Yamaguchi T, Nakazawa N, Mihashi T, Fujikado T: In vivo measurements of cone photoreceptor spacing in myopic eyes from images obtained by an adaptive optics fundus camera. Jpn J Ophthalmol 2007;51:456-461.
11.
Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF: Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009;148:445-450.
12.
Spaide RF, Koizumi H, Pozzoni MC: Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500.
13.
Rahaman W, Chen FK, Yeoh J, Patel P, Tufail A, Da Cruz L: Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:2267-2271.
14.
Branchini L, Regatieri CV, Flores-Moreno I, Baumann B, Fujimoto JG, Duker JS: Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012;119:119-123.
15.
Ikuno Y, Tano Y: Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2009;50:3876-3880.
16.
Flores-Moreno I, Lugo F, Duker JS, Ruiz-Moreno JM: The Relationship between axial length and choroidal thickness in eyes with high myopia. Am J Ophthalmol 2013;155:314-319.
17.
Nishida Y, Fujiwara T, Imamura Y, Lima LH, Kurosaka D, Spaide RF: Choroidal thickness and visual acuity in highly myopic eyes. Retina 2012;32:1229-1236.
18.
Schneider U, Kuck H, Inhoffen W, Kreissig I: Fundus-controlled microperimetry with the scanning laser ophthalmoscope in macular diseases. Klin Monatsbl Augenheilkd 1993;203:212-218.
19.
Varano M, Scassa C: Scanning laser ophthalmoscope microperimetry. Semin Ophthalmol 1998;13:203-209.
20.
Midena E, Radin PP, Pilotto E, Ghirlando A, Convento E, Varano M: Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age related macular degeneration. Semin Ophthalmol 2004;19:55-61.
21.
Gella L, Raman R, Sharma T: Evaluation of in vivo human retinal morphology and function in myopes. Curr Eye Res 2011;36:943-946.
22.
Qin Y, Zhu M, Qu X, Xu G, Yu Y, Witt RE, et al: Regional macular light sensitivity changes in myopic Chinese adults: an MP1 study. Invest Ophthalmol Vis Sci 2010;51:4451-4457.
23.
Fujii GY, de Juan E Jr, Sunness J, Humayun MS, Pieramici DJ, Chang TS: Patient Selection for Macular Translocation Surgery using the Scanning laser Ophthalmoscope. Ophthalmology 2002;109:1737-1744.
24.
Parravano M, Oddone F, Boccassini B, Chiaravalloti A, Scarinci F, Sciamanna M, et al: Functional and structural assessment of lamellar macular holes. Br J Ophthalmol 2013;97:291-296.
25.
Parravano M, Oddone F, Tedeschi M, Chiaravalloti A, Perillo L, Boccassini B, et al: Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results. Retina 2010;30:1017-1024.
26.
Horio N, Miyake Y, Horiguchi M: Kinetics of foveal cone photopigment in myopia without chorioretinal degeneration. Jpn J Ophthalmol 1999;43:44-47.
27.
Westall CA, Dhaliwal HS, Panton CM, Sigesmun D, Levin AV, Nischal KK, et al: Values of electroretinogram responses according to axial length. Doc Ophthalmol 2001;102:115-130.
28.
Kawabata H, Adachi-Usami E: Multifocal electroretinogram in myopia. Invest Ophthalmol Vis Sci 1997;38:2844-2851.
29.
Luu CD, Lau AM, Lee SY: Multifocal electroretinogram in adults and children with myopia. Arch Ophthalmol 2006;124:328-334.
30.
Chen JC, Brown B, Schmid KL: Delayed mfERG responses in myopia. Vision Res 2006;46:1221-1229.
31.
Flores-Moreno I, Ruiz-Medrano J, Duker JS, Ruiz-Moreno JM: The relationship between retinal and choroidal thickness and visual acuity in highly myopic eyes. Br J Ophthalmol 2013;97:1010-1013.
32.
Ho M, Liu DT, Chan VC, Lam DS: Choroidal thickness measurement in myopic eyes by enhanced depth optical coherence tomography. Ophthalmology 2013;120:1909-1914.
33.
Lin T, Grimes PA, Stone RA: Expansion of the retinal pigment epithelium in experimental myopia. Vision Res 1993;33:1881-1885.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.